December 31, 2019

In This Issue
Dr. John Yindra to Step Down from MMA Committee for Physician Quality
Licensing Boards Propose Rule Changes for Opioid Use Disorder Treatment, Pain Prescribing
Human Genome Editing is Here. How Should It Be Governed?
Five Big Medical Court Cases that Made a Difference in 2019
Agreement Reached On FY 2020 Federal Funding and Extender Package
This Week's Public Health Updates from the AMA
Vaccine Vote Update: Healthcare Advocates File Citizens' Guide Statements
Latest ACA Ruling: What it Means Now For Doctors, Patients
Opioid Related Webinars Offer CME Credit
Resources From The Alzheimer's Association
MMA Legislative Calls Will Begin Tuesday, January 14th
Maine Legislature's List of Bill Titles for 2020 Session: Initial Approval List
Upcoming Specialty Society Meetings
8-Hour Free Live Course for Buprenorphine Waiver Training @MMC - January 27th
MMA partners with the Maine Suicide Prevention Program and the Maine CDC/Sweetser to offer training for clinicians.
10th Annual Maine Patient Safety Academy - March 30, 2020
Orthopedic Surgeon Opportunity in Beautiful New England
Northern Light Sebasticook Valley Hospital seeks a BC/BE General Surgeon
Family Medicine Physician
Family Medicine Opportunity in Beautiful Western Maine
BC/BE Family Medicine or Internal Medicine Physician
Opportunities at the VA for Volunteer Physicians
Volunteer Opportunity with Partners for World Health - Portland, ME

Search Back Issues



Follow Us:
Human Genome Editing is Here. How Should It Be Governed?

[from the AMA Morning Rounds]

Gene editing is inexpensive, simple and becoming more widely used in clinical applications. One example is clustered regularly interspaced short palindromic repeats (CRISPR) genome editing, which is an efficient tool to introduce changes in DNA. Germline editing promises efficiency in eradicating many diseases, but ethical and legal questions persist about unknown, transgenerational and global consequences.

The December issue of the AMA Journal of Ethics® (@JournalofEthics) features numerous perspectives on governing human genome editing and gives you an opportunity to earn CME credit. 

Articles include: 

How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions?” Responding to patients violating U.S. health commerce regulations can be critical when they buy and use unproven interventions. 

Using the 4-S Framework to Guide Conversations With Patients About CRISPR.” Empathic communication skills help motivate understanding of safety, significance of harms, impact on succeeding generations, and social consequences. 

What Should Clinicians Do to Engage the Public About Gene Editing?” Clinicians should have a working understanding of gene editing, controversy surrounding its use, and its far-reaching clinical and ethical implications. 

How Should ‘CRISPRed’ Babies Be Monitored Over Their Life Course to Promote Health Equity?” Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation.


< Previous Article | Next Article >

[ return to top ]

To ensure delivery of Maine Medicine Weekly Update,
please add 'info@mainemed.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm

Unsubscribe here

For more information or to contact us directly, please visit www.mainemed.com | ©